Combination versus single-agent as palliative chemotherapy for gastric cancer

BACKGROUND: Although combination chemotherapy (CC) is generally recommended in recurrent or primary metastatic gastric cancer (RPMGC), the results of randomized trials are conflicting. METHODS: A retrospective review was conducted on 687 RPMGC patients who received palliative chemotherapy. We compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jin-Hyuk, Choi, Yong Won, Kang, Seok Yun, Jeong, Geum Sook, Lee, Hyun Woo, Jeong, Seong Hyun, Park, Joon Seong, Ahn, Mi Sun, Sheen, Seung Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052983/
https://www.ncbi.nlm.nih.gov/pubmed/32122320
http://dx.doi.org/10.1186/s12885-020-6666-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052983/
https://www.ncbi.nlm.nih.gov/pubmed/32122320
http://dx.doi.org/10.1186/s12885-020-6666-1

Ejemplares similares